Skip to main content
. 2012 Aug 30;7(8):e44165. doi: 10.1371/journal.pone.0044165

Table 2. Comparison of baseline clinical, echocardiographic, laboratory and procedural variables between patients with and without ERAF.

No ERAF n = 42 ERAF n = 26
Age (years) 58±12 62±9
Males/females (%) 69/31 58/42
Lone AF (%) 67 65
Paroxysmal AF/persistent AF (%) 62/38 54/46
AF history (months) 74±63 70±58
Body mass index (kg/m2) 28±4 30±4
Statins (%) 29 27
ACEI/ARB (%) 64 69
LVEF (%) 59±9 60±9
LAD (mm)* 42±6 45±6
Total ablation duration (min) 38±17 43±22
Total ablation power (J) 74.030±30.220 84.721±42.743
hs-CRP (µg/ml) at baseline 2.03±1.10 2.11±1.10
*

p<0.05; all other variables not significant.

Abbreviations as in Table 1.